Maximus, Inc. (FRA:MMY)

Market Cap	4.02B
Revenue (ttm)	4.62B
Net Income (ttm)	269.29M
Shares Out	n/a
EPS (ttm)	4.57
PE Ratio	14.92
Forward PE	10.65
Dividend	1.11 (1.67%)
Ex-Dividend Date	May 15, 2025

Volume	50
Average Volume	40
Open	66.50
Previous Close	63.50
Day's Range	66.50 - 66.50
52-Week Range	57.00 - 85.00
Beta	n/a
RSI	71.30
Earnings Date	Aug 6, 2025

About G1 Therapeutics

Maximus, Inc. operates as a provider of government services worldwide. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and...

• Industry: Management Services
• Founded: 1975
• Employees: 41,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MMY

Financial Performance

In 2024, Maximus's revenue was $5.31 billion, an increase of 8.19% compared to the previous year's $4.90 billion. Earnings were $306.91 million, an increase of 89.70%.